Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Jun 27, 2025, 4:00 PM
1.410
+0.030 (2.17%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $4.75 million as of June 27, 2025. Its market cap has decreased by -69.45% in one year.
Market Cap
4.75M
Enterprise Value
1.78M
1-Year Change
-69.45%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $4.75M, a decrease of -91.89%. That is a compound annual growth rate of -49.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.82M | -66.91% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |